Northern Biologics Inc. Company
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.
Industry:
PharmTech
Technology:
Anti-infective Drugs
Funding Status:
M&A
Estimated Revenue:
$1M to $10M
Investors Number:
3
Headquarters:
Canada
Employee Number:
11-50
Investor Type:
For Profit
Total Funding:
$20.7M
Founded Date:
2014
Last Funding Type:
Post-IPO Equity